福安药业集团庆余堂制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
123
NMPA:123
Drug Approvals
Oxacillin Sodium for Injection
- Product Name
- 注射用苯唑西林钠
- Approval Number
- 国药准字H20254446
- Approval Date
- Jun 3, 2025
NMPA
Oxacillin Sodium for Injection
- Product Name
- 注射用苯唑西林钠
- Approval Number
- 国药准字H20254447
- Approval Date
- Jun 3, 2025
NMPA
Metformin Hydrochloride and Empagliflozin Tablets（I）
- Product Name
- 二甲双胍恩格列净片(Ⅰ)
- Approval Number
- 国药准字H20253045
- Approval Date
- Jan 2, 2025
NMPA
Ticarcillin Disodium and Clavulanate Potassium for Injection
- Product Name
- 注射用替卡西林钠克拉维酸钾
- Approval Number
- 国药准字H20103008
- Approval Date
- Oct 17, 2024
NMPA
Ticarcillin Disodium and Clavulanate Potassium for Injection
- Product Name
- 注射用替卡西林钠克拉维酸钾
- Approval Number
- 国药准字H20103007
- Approval Date
- Oct 17, 2024
NMPA
Butorphanol Tartrate Injection
- Product Name
- 酒石酸布托啡诺注射液
- Approval Number
- 国药准字H20247242
- Approval Date
- Oct 15, 2024
NMPA
Norepinephrine Bitartrate Injection
- Product Name
- 重酒石酸去甲肾上腺素注射液
- Approval Number
- 国药准字H20244996
- Approval Date
- Sep 26, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
Clinical Trials
No trials found
News
No news found